Supply 99% Purity High Quality Mildronate Raw Powder CAS 76144-81-5

• Powder: Yes
• Customized: Non-Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >99%
• Model NO.: TGY-2023052301
• Product Name: Mildronate
• MOQ: 1kg
• Storage: Cool Dry Place
• Mf: C6h14n2o2
• MW: 146.19
• Color: White
• Sample: Available
• Transport Package: 1kg/Foil Bag 25kg/Drum
• Specification: HPLC 99%
• Trademark: TGY
• Origin: Xi′an, Shaanxi, China
• HS Code: 2019051403
• Production Capacity: 5500kg/Month

Product Description

Mildronate is a structural analog of carnitine that competes in the inhibition of butyrate betaine hydroxylase, thereby inhibiting the biosynthesis of carnitine, which directly inhibits the transport of carnitine-dependent fatty acids in mitochondria. Inhibition of carnitine biosynthesis can reduce the concentration of intracellular free carnitine and prevent isoproterenol-induced acyl carnitine accumulation. Therefore, the drug has a significant protective effect on the myocardium, resulting in this protective effect at the same time on the hemodynamic parameters had no significant effect, cardiac blood supply and cardiac oxygen consumption was no significant change.

Product Name	Mildronate
CAS NO.	76144-81-5
Purity	99%
Grade Standard	Medical Standard
MF	C6H14N2O2
MW	146.18756
Test Method	HPLC
Other Name	Mildronate Powder
Appearance	White Powder
Brand	MT

Cardiovascular disease - stable angina, chronic heart failure, cardiomyopathy, functional cardiovascular system failure;

Acute and chronic ischemic attacks;

The ability to work under high physical and psychological load decreases;

Recovery from cerebrovascular disease, brain injury, and encephalitis.

Alcohol withdrawal symptoms.

1. Mildronate powder is a novel cardioprotective agent.

2.Mildronate acts on mitochondria at the cellular level to improve myocardial energy metabolism. In view of these drugs and other anti-myocardial ischemia significantly different, also known as cell anti-ischemic drugs.

3. Mildronate is a structural analog of carnitine that competes in the inhibition of butyrate betaine hydroxylase, thereby inhibiting the biosynthesis of carnitine, which directly inhibits the transport of carnitine-dependent fatty acids in mitochondria. Inhibition of carnitine biosynthesis can reduce the concentration of intracellular free carnitine and prevent isoproterenol-induced acyl carnitine accumulation.